Clinical Trial Update: BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intracoronary reinfusion of bone marrow-derived mononuclear cells after acute myocardial infarction; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• bone marrow-derived mononuclear cells

Snippet

Sponsor: Queen Mary University of London | Conditions: Myocardial Infarction, Death | Phase 3 | Status: COMPLETED